To delineate the expression profile of TRIM44 in MM patients across different stages of the disease, we analyzed single-cell RNA-sequencing data from 29,387 plasma cells representing 26 samples from patients with MGUS, SMM, or MM in addition to nine samples from normal bone marrow donors (NBM) [27]. This evidence concerns the gene TRIM44 and Miyoshi myopathy.